{
  "subset": "contraindication",
  "disease": "Neonatal cholestasis",
  "relation": "contraindication",
  "gold_drugs": [
    "lum001"
  ],
  "seeds_initial": [
    "Phenobarbital",
    "Cholestyramine",
    "Sodium valproate",
    "Ibuprofen",
    "Acetaminophen",
    "Ciprofloxacin",
    "Amitriptyline",
    "Estrogens",
    "Azathioprine",
    "Methotrexate",
    "Rifampicin",
    "Furosemide",
    "Naltrexone",
    "Digoxin",
    "Isoniazid",
    "ACE inhibitors",
    "Bromocriptine",
    "Carbamazepine",
    "Dapsone",
    "HMG-CoA reductase inhibitors",
    "Glibenclamide",
    "NSAIDs",
    "Sildenafil",
    "Sodium nitroprusside",
    "Theophylline",
    "Tetracycline",
    "Valproate",
    "Warfarin",
    "Amiodarone",
    "Chlorpromazine",
    "Dexamethasone",
    "Fluconazole",
    "Ketoconazole",
    "Nifedipine",
    "Nitrofurantoin",
    "Rifampin",
    "Simvastatin",
    "Tricyclic antidepressants",
    "Amphotericin B",
    "Clofazimine",
    "Metranidazole",
    "Vancomycin",
    "Tobramycin",
    "Cimetidine",
    "Labetalol",
    "Probenecid",
    "Temazepam",
    "Diltiazem",
    "Quinidine",
    "Paroxetine",
    "Risperidone",
    "Rosuvastatin",
    "Gemfibrozil",
    "Clindamycin",
    "Benzodiazepines",
    "Methyldopa",
    "Thalidomide",
    "Thyroid hormones",
    "Oxcarbazepine"
  ],
  "seed_history": [
    [
      "Phenobarbital",
      "Cholestyramine",
      "Sodium valproate",
      "Ibuprofen",
      "Acetaminophen",
      "Ciprofloxacin",
      "Amitriptyline",
      "Estrogens",
      "Azathioprine",
      "Methotrexate",
      "Rifampicin",
      "Furosemide",
      "Naltrexone",
      "Digoxin",
      "Isoniazid",
      "ACE inhibitors",
      "Bromocriptine",
      "Carbamazepine",
      "Dapsone",
      "HMG-CoA reductase inhibitors",
      "Glibenclamide",
      "NSAIDs",
      "Sildenafil",
      "Sodium nitroprusside",
      "Theophylline",
      "Tetracycline",
      "Valproate",
      "Warfarin",
      "Amiodarone",
      "Chlorpromazine",
      "Dexamethasone",
      "Fluconazole",
      "Ketoconazole",
      "Nifedipine",
      "Nitrofurantoin",
      "Rifampin",
      "Simvastatin",
      "Tricyclic antidepressants",
      "Amphotericin B",
      "Clofazimine",
      "Metranidazole",
      "Vancomycin",
      "Tobramycin",
      "Cimetidine",
      "Labetalol",
      "Probenecid",
      "Temazepam",
      "Diltiazem",
      "Quinidine",
      "Paroxetine",
      "Risperidone",
      "Rosuvastatin",
      "Gemfibrozil",
      "Clindamycin",
      "Benzodiazepines",
      "Methyldopa",
      "Thalidomide",
      "Thyroid hormones",
      "Oxcarbazepine"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_phenobarbital",
          "name": "Phenobarbital"
        },
        "score": 0.63,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Phenobarbital 对胆道病症存在已知影响",
          "不良反应可能抵消其治疗获益"
        ],
        "caveats": [
          "在与其他疗法的比较中缺乏证据"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "score": 0.58,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Cholestyramine 有效治疗肝胆相关病症的机制",
          "不良反应可能抵消其治疗获益"
        ],
        "caveats": [
          "在与其他疗法的比较中缺乏证据"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_sodium_valproate",
          "name": "Sodium Valproate"
        },
        "score": 0.55,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Sodium Valproate 能辅助治疗胆道问题",
          "不良反应可能抵消其治疗获益"
        ],
        "caveats": [
          "在与其他疗法的比较中缺乏证据"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Disease (胆道病症)",
          "reason": "已有有效数据支持指定药物的适用性"
        }
      ],
      "remaining_gaps": [
        "缺乏有效的疗效对比数据，限制了推荐的信心",
        "潜在的安全风险需要进一步评估"
      ]
    },
    "heuristics": [
      {
        "when": "对胆道问题的药物治疗",
        "then": "优先考虑已知疗效与不良反应的平衡"
      }
    ]
  }
}